Status:
COMPLETED
A Randomized Trial of Oral Iron Therapy in Fibromyalgia
Lead Sponsor:
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Conditions:
Primary Fibromyalgia
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
Fibromyalgia (FM) is a disorder with chronic widespread musculoskeletal pain for which no alternative cause can be identified. The condition is often accompanied by other features such as fatigue, sti...
Detailed Description
Fibromyalgia (FM) is a disorder with chronic widespread musculoskeletal pain for which no alternative cause can be identified . The condition is often accompanied by other features such as fatigue, st...
Eligibility Criteria
Inclusion
- Patients of Fibromyalgia fulfilling ACR 2010 criteria.
- Patients with a baseline FIQ \>40 will be taken up for study.
Exclusion
- Patients with a Hb\<8 g or having hypothyroidism , deficiency of Vitamin D or any connective tissue disease will be excluded from the study.
- Baseline depression will be assessed using BPHQ and patients with a baseline BPHQ \> 4 will be excluded from study.
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01820052
Start Date
April 1 2013
End Date
December 1 2015
Last Update
April 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SGPGIMS
Lucknow, Uttar Pradesh, India, 226014